Management Team

Mr. Marotta joined Azenta Life Sciences in September 2024 as President and CEO. He has two decades of experience leading global companies in life sciences, medical devices, and diagnostics.

Prior to joining the company, Mr. Marotta served as Executive in Residence of Patient Square Capital, a leading healthcare investment firm. Previously, he served as CEO and President of PHC Holdings Corporation (formerly Panasonic Health Care), a diversified global life sciences, diagnostics, and medical device company focused on precision healthcare, growing global revenues, and leading its IPO from owners KKR Capital. He also held a variety of senior executive roles in leading life sciences companies, including Danaher, Envista Holdings, and Cardinal Health, where he demonstrated consistent achievement in organic revenue growth, operational efficiencies, and significant value-creating transactions. Mr. Marotta began his career in sales leadership roles for therapeutics and medical device offerings.

Mr. Marotta received his BS from the University of Dayton and his MBA from the University of Denver, Daniels School of Business.

Mr. Lin joined Azenta in November 2024 as Executive Vice President and Chief Financial Officer and brings over twenty years of finance experience.

Prior to joining Azenta, Mr. Lin was Chief Financial Officer at GeoStabilization International LLC (“GSI”), a privately held industrial company, and Senior Vice President of Finance Operations at PHC Holdings Corporation, a leading diversified diagnostic, life sciences and medical device company based in Japan. Prior roles include Vice President of Finance for North America (CFO) and Global Functions at LivaNova, a global medical technology company, and Vice President of Finance Operations at KaVo Kerr, previously part of Danaher, which was spun off as an independent public company named Envista in 2019.

Mr. Lin holds a bachelor’s degree in finance from California State University, Fullerton.

Dr. Ginger Zhou joined Azenta Life Sciences in November 2018 and was appointed Senior Vice President and General Manager of the GENEWIZ Multiomics and Synthesis Solutions business in November 2022. She holds primary responsibility for leading global GENEWIZ Multiomics and Synthesis Solutions business growth, operations, and development of related products and solutions.

Dr. Zhou joined Azenta in November 2018 as part of the acquisition of GENEWIZ. In her 7 years with GENEWIZ, Dr. Zhou held various leadership positions including VP of Global Next Generation Sequencing.

Dr. Zhou received her Ph.D. in Molecular Biology and Biochemistry from The State University of New York through a joint research program with Yale University. She holds a B.S. in Biochemical Engineering from Tianjin University, China.

Mr. Provost joined Azenta Life Sciences in October 2022 as Vice President & CEO of B Medical Systems. He holds primary responsibility for leading the B Medical business growth and operations. In his role, Mr. Provost has traveled to 100+ countries and has worked closely with several central governments, ministries of health, international humanitarian and procurement organizations like UNICEF, WHO, etc.

Mr. Provost joined Azenta in October 2022 as part of the acquisition of B Medical. In his 24 years with B Medical, he has played a pivotal role in the company’s revenue growth, geographic expansions and has signed various global commercial agreements for the Company.

Mr. Provost received his decree in Business and Management from the University of Louvain in Belgium and has studied International Marketing at Laval University in Quebec.

Mrs. Olga Pirogova joined Azenta Life Sciences in August 2023 as Senior Vice President and Chief Human Resources Officer (CHRO). Ms. Pirogova is responsible for developing and executing Azenta’s human resources strategy in support of the overall business plan and strategic direction of the company.

Prior to Azenta, Ms. Pirogova served as CHRO at Speedcast, a global satellite communications service provider. Ms. Pirogova also spent 12 years with BD (Becton, Dickinson & Company), a leading global medical technology company, where she worked in various Human Resources leadership roles across Latin America, Europe, and the United States. She previously worked at British Petroleum and Phillip Morris International, where she held roles in a wide range of HR disciplines.

Ms. Pirogova received her master’s degree in human development from Ibero-American University in Mexico City and completed her undergraduate degree at Minsk State Linguistic University in Belarus.

Mr. Starr joined Azenta Life Sciences in May 2025 as Senior Vice President, General Counsel & Corporate Secretary, overseeing all aspects of the company’s legal affairs. His responsibilities include corporate governance, intellectual property, securities, commercial contracts, litigation, compliance, and regulatory matters. He also serves as Secretary to both the Corporation and its Board of Directors.

With over 30 years of legal and business experience across the life sciences, water, computing, and industrial sectors, Mr. Starr brings a wealth of strategic and operational expertise. Prior to joining Azenta, he led the Private Equity Practice at Lean Focus, a consulting firm recognized for cultivating high-performance cultures and driving sustainable, profitable growth. Previously, Mr. Starr served as General Counsel and Corporate Officer at PHC Holdings, where he played a key role in taking the company public and establishing its M&A and governance frameworks. He has also held executive legal roles at Danaher, Lenovo, and Honeywell, where he championed operational efficiency, innovation, and strategic risk management to support business growth. Mr. Starr began his legal career in the intellectual property and litigation departments of Kirkland & Ellis LLP.

He holds a J.D. from Duke University School of Law and a B.A. in English and Physics from Amherst College. He is a registered U.S. Patent Attorney and is licensed to practice law in California and Colorado.

Mr. Paulo joined Azenta Life Sciences in July 2017 as Vice President and Chief Information & Digital Officer. As the Chief Information & Digital Officer Mr. Paulo provides the strategic vision, operational plan, and execution for the technology enablement of the business, enabling the continual positive transformation and progression of the global business.

Mr. Paulo began his career at Automatic Switch Co. in Florham Park New Jersey which was acquired by Emerson Electric Co. based in St. Louis Missouri. Over the course of the next twenty-seven years at Emerson, Mr. Paulo held increasing roles of global responsibility across several key divisions of Emerson, each serving different global industries from healthcare to data centers and telecom: CIO at ASCO Power Technologies, CIO at Energy Systems, CIO at Liebert, and CIO Americas and VP Global Transformation at Emerson’s Network Power business platform which became Vertiv, a $4B annual revenue global business with a footprint in over 147 countries.

Mr. Paulo received his Bachelor’s degree in Electrical Engineering and MBA from Rutgers University. He also holds several certifications spanning the Information Technology & Information Systems profession.

Mr. Woodward joined Azenta Life Sciences in November 2009 and was appointed Senior Vice President, Global Quality & Regulatory in November 2019. He is primarily responsible for ensuring Azenta products meet customer expectations while complying with all applicable regulatory and standards requirements. Mr. Woodward is on international assignment based in our Manchester, England site.

Over the past decade at Azenta, Mr. Woodward has held engineering and quality leadership roles with increasing responsibilities. Prior to Azenta, Mr. Woodward worked for United Technologies’ Carrier Corporation where he was the engineering leader for compressor systems technology and components group. He also spent over 16 years at General Electric in various engineering leadership roles.

Mr. Woodward holds BS and MS degrees in Chemistry from Furman University.

Mr. Marotta joined Azenta Life Sciences in September 2024 as President and CEO. He has two decades of experience leading global companies in life sciences, medical devices, and diagnostics.

Prior to joining the company, Mr. Marotta served as Executive in Residence of Patient Square Capital, a leading healthcare investment firm. Previously, he served as CEO and President of PHC Holdings Corporation (formerly Panasonic Health Care), a diversified global life sciences, diagnostics, and medical device company focused on precision healthcare, growing global revenues, and leading its IPO from owners KKR Capital. He also held a variety of senior executive roles in leading life sciences companies, including Danaher, Envista Holdings, and Cardinal Health, where he demonstrated consistent achievement in organic revenue growth, operational efficiencies, and significant value-creating transactions. Mr. Marotta began his career in sales leadership roles for therapeutics and medical device offerings.

Mr. Marotta received his BS from the University of Dayton and his MBA from the University of Denver, Daniels School of Business.

Mr. Lin joined Azenta in November 2024 as Executive Vice President and Chief Financial Officer and brings over twenty years of finance experience.

Prior to joining Azenta, Mr. Lin was Chief Financial Officer at GeoStabilization International LLC (“GSI”), a privately held industrial company, and Senior Vice President of Finance Operations at PHC Holdings Corporation, a leading diversified diagnostic, life sciences and medical device company based in Japan. Prior roles include Vice President of Finance for North America (CFO) and Global Functions at LivaNova, a global medical technology company, and Vice President of Finance Operations at KaVo Kerr, previously part of Danaher, which was spun off as an independent public company named Envista in 2019.

Mr. Lin holds a bachelor’s degree in finance from California State University, Fullerton.

Dr. Ginger Zhou joined Azenta Life Sciences in November 2018 and was appointed Senior Vice President and General Manager of the GENEWIZ Multiomics and Synthesis Solutions business in November 2022. She holds primary responsibility for leading global GENEWIZ Multiomics and Synthesis Solutions business growth, operations, and development of related products and solutions.

Dr. Zhou joined Azenta in November 2018 as part of the acquisition of GENEWIZ. In her 7 years with GENEWIZ, Dr. Zhou held various leadership positions including VP of Global Next Generation Sequencing.

Dr. Zhou received her Ph.D. in Molecular Biology and Biochemistry from The State University of New York through a joint research program with Yale University. She holds a B.S. in Biochemical Engineering from Tianjin University, China.

Mr. Provost joined Azenta Life Sciences in October 2022 as Vice President & CEO of B Medical Systems. He holds primary responsibility for leading the B Medical business growth and operations. In his role, Mr. Provost has traveled to 100+ countries and has worked closely with several central governments, ministries of health, international humanitarian and procurement organizations like UNICEF, WHO, etc.

Mr. Provost joined Azenta in October 2022 as part of the acquisition of B Medical. In his 24 years with B Medical, he has played a pivotal role in the company’s revenue growth, geographic expansions and has signed various global commercial agreements for the Company.

Mr. Provost received his decree in Business and Management from the University of Louvain in Belgium and has studied International Marketing at Laval University in Quebec.

Mrs. Olga Pirogova joined Azenta Life Sciences in August 2023 as Senior Vice President and Chief Human Resources Officer (CHRO). Ms. Pirogova is responsible for developing and executing Azenta’s human resources strategy in support of the overall business plan and strategic direction of the company.

Prior to Azenta, Ms. Pirogova served as CHRO at Speedcast, a global satellite communications service provider. Ms. Pirogova also spent 12 years with BD (Becton, Dickinson & Company), a leading global medical technology company, where she worked in various Human Resources leadership roles across Latin America, Europe, and the United States. She previously worked at British Petroleum and Phillip Morris International, where she held roles in a wide range of HR disciplines.

Ms. Pirogova received her master’s degree in human development from Ibero-American University in Mexico City and completed her undergraduate degree at Minsk State Linguistic University in Belarus.

Mr. Starr joined Azenta Life Sciences in May 2025 as Senior Vice President, General Counsel & Corporate Secretary, overseeing all aspects of the company’s legal affairs. His responsibilities include corporate governance, intellectual property, securities, commercial contracts, litigation, compliance, and regulatory matters. He also serves as Secretary to both the Corporation and its Board of Directors.

With over 30 years of legal and business experience across the life sciences, water, computing, and industrial sectors, Mr. Starr brings a wealth of strategic and operational expertise. Prior to joining Azenta, he led the Private Equity Practice at Lean Focus, a consulting firm recognized for cultivating high-performance cultures and driving sustainable, profitable growth. Previously, Mr. Starr served as General Counsel and Corporate Officer at PHC Holdings, where he played a key role in taking the company public and establishing its M&A and governance frameworks. He has also held executive legal roles at Danaher, Lenovo, and Honeywell, where he championed operational efficiency, innovation, and strategic risk management to support business growth. Mr. Starr began his legal career in the intellectual property and litigation departments of Kirkland & Ellis LLP.

He holds a J.D. from Duke University School of Law and a B.A. in English and Physics from Amherst College. He is a registered U.S. Patent Attorney and is licensed to practice law in California and Colorado.

Mr. Paulo joined Azenta Life Sciences in July 2017 as Vice President and Chief Information & Digital Officer. As the Chief Information & Digital Officer Mr. Paulo provides the strategic vision, operational plan, and execution for the technology enablement of the business, enabling the continual positive transformation and progression of the global business.

Mr. Paulo began his career at Automatic Switch Co. in Florham Park New Jersey which was acquired by Emerson Electric Co. based in St. Louis Missouri. Over the course of the next twenty-seven years at Emerson, Mr. Paulo held increasing roles of global responsibility across several key divisions of Emerson, each serving different global industries from healthcare to data centers and telecom: CIO at ASCO Power Technologies, CIO at Energy Systems, CIO at Liebert, and CIO Americas and VP Global Transformation at Emerson’s Network Power business platform which became Vertiv, a $4B annual revenue global business with a footprint in over 147 countries.

Mr. Paulo received his Bachelor’s degree in Electrical Engineering and MBA from Rutgers University. He also holds several certifications spanning the Information Technology & Information Systems profession.

Mr. Woodward joined Azenta Life Sciences in November 2009 and was appointed Senior Vice President, Global Quality & Regulatory in November 2019. He is primarily responsible for ensuring Azenta products meet customer expectations while complying with all applicable regulatory and standards requirements. Mr. Woodward is on international assignment based in our Manchester, England site.

Over the past decade at Azenta, Mr. Woodward has held engineering and quality leadership roles with increasing responsibilities. Prior to Azenta, Mr. Woodward worked for United Technologies’ Carrier Corporation where he was the engineering leader for compressor systems technology and components group. He also spent over 16 years at General Electric in various engineering leadership roles.

Mr. Woodward holds BS and MS degrees in Chemistry from Furman University.